VitaSpring Biomedical Co. Ltd.
Cash Flow Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-6.4K | $-45 |
| Depreciation & Amortization | — | — |
| Depreciation | $375 | $0 |
| Amortization | — | — |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $401 | $-4.0K |
| Investing Activities | ||
| Capital Expenditures | — | — |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-2.2K | $0 |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | $100 | — |
| Net Cash from Financing Activities | $6.5K | $4.6K |
| Net Change in Cash | — | — |
| Free Cash Flow | — | — |